Shenzhen Mindray Bio-Medic-A
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$39.84avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Shenzhen Mindray Bio-Medic-A in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Boston Common Asset Management, LLC ($5.5M).
- Company
- Shenzhen Mindray Bio-Medic-A
- CUSIP
- Y774E3101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 18,686 shares bought, net +18,686 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Boston Common Asset Management, LLC | 0.14% | Add +15.7% | 138,040 | $5.5M |
"% of holder's portfolio" is SHENZHEN MINDRAY BIO-MEDIC-A's weight in each manager's 13F, not the share of Shenzhen Mindray Bio-Medic-A the manager owns.